Application Notes & Case Studies

  1. Tailored Solutions For A Global Phase III Neovascular AMD Study 3/17/2025

    How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?

  2. Recruiting & Retaining More Patients Per Site: 3/14/2025

    Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.

  3. Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence 3/10/2025

    A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.

  4. GSK And Medable Discuss The Next Phase Of DCTs 3/10/2025

    GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

  5. Supporting Study Set Up In Just 4 To 6 Weeks 3/4/2025

    Facing challenges in cycle times, quality control, and visibility, a global CRO adopted Medidata’s Rave Imaging, integrating it with its existing Rave EDC system to create a seamless digital workflow.

  6. Biotech Delivers A Superior Patient And Site Experience 3/4/2025

    To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.

  7. Transforming Clinical Trial Sites With Research Study Rockstar 2/10/2025

    This innovative platform addresses prevalent pain points faced by trial coordinators by streamlining workflows, automating patient communication, and providing intuitive dashboards that simplify trial management.

  8. Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan 2/7/2025

    A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.

  9. 6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies 2/3/2025

    Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.

  10. 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development 2/3/2025

    Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.